Regents of the University of California’s Cardlytics CDLX Stock Holding History

Regents of the University of California’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,905	Closed	-$495K	–	28
2019 Q2	$495K	Buy	+1,905	New	+$381K	1.4%	20
2019 Q1	–	Sell	-3,590	Closed	-$389K	–	24
2018 Q4	$389K	Sell	3,590 -1,795	-33%	-$303K	0.94%	22
2018 Q3	$1.35M	Buy	+5,385	New	+$1.16M	2.62%	9

Other funds holding CDLX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Regents of the University of California's CDLX Position: Q3 2019 in Review

Regents of the University of California sold out of Cardlytics (CDLX) in Q3 2019, closing a stake of 1,905 shares — an estimated $495K sold.

Regents of the University of California first reported a position in CDLX in Q3 2018 and held it in 3 quarters. The position peaked at $1.35M in Q3 2018. 117 funds tracked by Wall St. Rank hold CDLX as of Q3 2019.

Regents of the University of California reported no remaining Cardlytics position as of Q3 2019 after selling out during the quarter.
Regents of the University of California sold 1,905 Cardlytics shares in Q3 2019, an estimated $495K.
Regents of the University of California first reported a position in Cardlytics in Q3 2018 and held it in 3 quarters.
Regents of the University of California's Cardlytics position peaked at $1.35M in Q3 2018.
117 funds tracked by Wall St. Rank held Cardlytics as of Q3 2019.

Based on Regents of the University of California's 13F filing for Q3 2019, filed 13 Nov 2019.